IFP Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.84M Buy
38,760
+3,133
+9% +$730K 0.18% 123
2026
Q1
$8.71M Sell
35,627
-1,061
-3% -$247K 0.18% 121
2025
Q4
$7.59M Buy
36,688
+4,273
+13% +$845K 0.17% 123
2025
Q3
$6.01M Buy
32,415
+627
+2% +$107K 0.16% 139
2025
Q2
$4.86M Sell
31,788
-1,543
-5% -$237K 0.14% 161
2025
Q1
$5.53M Buy
33,331
+1,079
+3% +$169K 0.17% 124
2024
Q4
$4.66M Buy
32,252
+1,873
+6% +$290K 0.15% 141
2024
Q3
$4.92M Buy
30,379
+2,668
+10% +$425K 0.18% 124
2024
Q2
$4.05M Buy
27,711
+708
+3% +$105K 0.16% 130
2024
Q1
$4.27M Sell
27,003
-4,316
-14% -$687K 0.19% 117
2023
Q4
$4.91M Sell
31,319
-7,783
-20% -$1.19M 0.23% 92
2023
Q3
$6.09M Sell
39,102
-2,378
-6% -$392K 0.27% 81
2023
Q2
$6.87M Sell
41,480
-22,689
-35% -$3.66M 0.29% 73
2023
Q1
$7.33M Sell
64,169
-33,675
-34% -$5.44M 0.32% 58
2022
Q4
$11.2M Buy
97,844
+3,670
+4% +$634K 0.3% 62
2022
Q3
$10.8M Buy
94,174
+4,993
+6% +$845K 0.28% 71
2022
Q2
$10.2M Hold
89,181
0.33% 65
2022
Q1
$10.2M Buy
89,181
+30,025
+51% +$5.11M 0.33% 65
2021
Q4
$10.1M Buy
59,156
+1,329
+2% +$218K 0.2% 53
2021
Q3
$9.34M Buy
57,827
+1,343
+2% +$229K 0.19% 59
2021
Q2
$9.25M Sell
56,484
-366
-0.6% -$60.6K 0.19% 57
2021
Q1
$9.31M Buy
56,850
+1,782
+3% +$288K 0.18% 52
2020
Q4
$8.67M Buy
55,068
+1,524
+3% +$225K 0.35% 43
2020
Q3
$7.95M Buy
53,544
+3,832
+8% +$567K 0.47% 40
2020
Q2
$6.92M Buy
49,712
+5,311
+12% +$774K 0.55% 33
2020
Q1
$5.63M Buy
44,401
+4,207
+10% +$597K 0.57% 33
2019
Q4
$5.87M Sell
40,194
-13,807
-26% -$1.87M 0.44% 44
2019
Q3
$6.95M Buy
+54,001
New +$7.11M 0.47% 44
2019
Q1
$3.29M Sell
23,500
-48,209
-67% -$6.46M 0.45% 37
2018
Q4
$9.13M Sell
71,709
-29,764
-29% -$4.15M 0.56% 28
2018
Q3
$14M Buy
101,473
+935
+0.9% +$124K 0.57% 22
2018
Q2
$12.2M Sell
100,538
-4,061
-4% -$507K 0.51% 27
2018
Q1
$14.6M Hold
104,599
0.66% 17
2017
Q4
$14.6M Sell
104,599
-75,841
-42% -$10.6M 0.66% 17
2017
Q3
$23.5M Buy
180,440
+2,226
+1% +$295K 0.93% 11
2017
Q2
$23.6M Buy
178,214
+44,416
+33% +$5.67M 1% 10
2017
Q1
$16.7M Sell
133,798
-4,817
-3% -$575K 0.73% 15
2016
Q4
$16M Buy
138,615
+14,853
+12% +$1.72M 0.77% 16
2016
Q3
$14.6M Sell
123,762
-549
-0.4% -$66.6K 0.76% 17
2016
Q2
$15.1M Buy
124,311
+100,811
+429% +$11.5M 0.84% 14
2016
Q1
$3.29M Sell
23,500
-80,834
-77% -$8.37M 0.45% 37
2015
Q4
$10.7M Buy
+104,334
New +$10.5M 0.72% 16

Other funds holding JNJ

IFP Advisors's JNJ Position: Q2 2026 in Review

IFP Advisors increased its Johnson & Johnson (JNJ) stake by 8.8% in Q2 2026, buying an estimated $730K and bringing the position to 38,760 shares worth $9.84M. The position accounts for 0.18% of the portfolio, ranked #123.

IFP Advisors first reported a position in JNJ in Q4 2015 and has held it in 42 quarters since. The position peaked at $23.6M in Q2 2017. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • IFP Advisors held 38,760 shares of Johnson & Johnson worth $9.84M as of Q2 2026.
  • IFP Advisors bought 3,133 Johnson & Johnson shares in Q2 2026, an estimated $730K.
  • Johnson & Johnson made up 0.18% of IFP Advisors's portfolio in Q2 2026, its #123 holding.
  • IFP Advisors first reported a position in Johnson & Johnson in Q4 2015 and has held it in 42 quarters since.
  • IFP Advisors's Johnson & Johnson position peaked at $23.6M in Q2 2017.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.